HDAC1 and neoplasm: In addition to being involved in cancers such as AML, PCa, and liver cancer, TRIB1 can also regulate tumor cell activity through pathways such as PI3K/AKT, HDAC1/p53 and C/EBPα, thereby affecting the resistance of tumor cells (Figure 1).